Details for New Drug Application (NDA): 018911
✉ Email this page to a colleague
NDA 018911 describes HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.45%, which is a drug marketed by Hospira and is included in two NDAs. It is available from two suppliers. Additional details are available on the HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.45% profile page.
The generic ingredient in HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.45% is heparin sodium. There are seventy-seven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
The generic ingredient in HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.45% is heparin sodium. There are seventy-seven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
Summary for 018911
| Tradename: | HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.45% |
| Applicant: | Hospira |
| Ingredient: | heparin sodium |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 10,000 UNITS/100ML | ||||
| Approval Date: | Jan 30, 1985 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 100 UNITS/ML | ||||
| Approval Date: | Jan 30, 1985 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 10,000 UNITS/100ML | ||||
| Approval Date: | Jan 30, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
